Revolution Medicines Inc. (NASDAQ: RVMD) will present updated clinical data for its cancer drug daraxonrasib at the American Association for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE